Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
70.20    0.00 (0.00%)
Bid:
67.00
Ask:
70.00
Spread: 3.00 (4.478%)
Market Cap: £94.75m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Completion of Acquisition

17 Oct 2005 09:52

Trifast PLC17 October 2005 Issued by Citigate Dewe Rogerson Limited, BirminghamDate: Monday 17 October 2005 Immediate Release NOT FOR RELEASE OR DISTRIBUTION IN OR INTO THE USA, CANADA, THE REPUBLIC OF IRELAND, AUSTRALIA OR JAPAN Trifast plc Completion of the Acquisition of Serco Ryan Limited and Appointment of Executive Director Further to the announcement of 20 September 2005, Trifast plc is pleased toannounce the successful completion of the acquisition of Serco Ryan Limited.The 11,940,298 Placing and Open Offer Shares pursuant to the Acquisition have been admitted to the Official List and commenced trading with effect from 8.00 a.m.this morning. Following the successful completion of the Acquisition, Steve Auld, ManagingDirector of Serco Ryan, becomes an Executive Director of Trifast and joins theBoard with immediate effect. Steve will continue in his role as ManagingDirector of the Serco Ryan businesses and provide additional support to theEuropean operations of Trifast. Steve (aged 45) has a wealth of commercial experience gained over 24 yearsworking within the fastening industry. He joined Serco Ryan in 1990 as Sales &Marketing Director and in July 2004 he was appointed Managing Director tooversee the significant reorganisation of the Serco Ryan business. In addition to his role at Serco Ryan, Steve is also Chairman of the BritishAssociation of Fastener Distributors (BAFD) and Vice President of the EuropeanFastener Distributor Association (EFDA). Enquiries:Trifast plc Citigate Dewe RogersonJim Barker, Chief Executive Fiona TooleyStuart Lawson, Group Finance Director Tel: +44(0)121 455 8370Tel: +44 (0)1825 747200 Mobile: +44 (0)7785 703523Website: www.trifast.com N M Rothschild & Sons Limited Ravi Gupta Tel: +44 (0)20 7280 5000 Arden Partners Limited Richard Day Tel: +44 (0)20 7398 1632 Terms defined in the announcement of the Company on 20 September 2005 bear thesame meaning when used in this announcement. N M Rothschild & Sons Limited, which is authorised and regulated in the UnitedKingdom by the Financial Services Authority, is acting exclusively for Trifastplc in connection with the Acquisition and is neither advising nor treating as aclient any other person and will not be responsible to anyone other than Trifastplc for providing the protections afforded to clients of N M Rothschild & SonsLimited nor for providing advice in relation to the Acquisition. Arden Partners Limited, which is authorised and regulated in the United Kingdomby the Financial Services Authority, is acting exclusively for Trifast plc inconnection with the Placing and Open Offer. Arden Partners Limited will not beresponsible to anyone other than Trifast plc for providing the protectionsoffered to clients of Arden Partners Limited nor for providing advice inrelation to the Placing and Open Offer. Neither the Placing nor the Open Offer is being made, directly or indirectly, inor into, or by use of the mails, or by any means or instrumentality (including,without limitation, facsimile transmission, internet, email, telex or telephone)of interstate or foreign commerce, or of any facility of a national securitiesexchange, of the United States, Canada, Australia, Japan or the Republic ofIreland and neither can be accepted by any such use, means instrumentality orfacility or from within the United States, Canada, Australia, Japan or theRepublic of Ireland. Neither the Placing nor the Open Offer constitutes an offer of securities forsale, or the solicitation of an offer to buy securities in the United States andthe new Ordinary Shares to be issued pursuant to the Placing and the Open Offerhave not been and will not be registered under the United States Securities Actof 1933, or under the laws of any state, district or other jurisdiction of theUnited States or of Canada, Australia, Japan or the Republic of Ireland and noregulatory clearances in respect of new Ordinary Shares have been or will be,applied for in any jurisdiction. Accordingly, unless an exemption under the USSecurities Act of 1933 or other relevant securities laws is applicable, the newOrdinary Shares are not being, and may not be offered, sold, resold, deliveredor distributed, directly or indirectly, in or into the United States or Canada,Australia, Japan or the Republic of Ireland or to, or for the account or benefitof, any US person or person resident in Canada, Australia, Japan or the Republicof Ireland. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Jun 20269:33 amRNSHolding(s) in Company
11th Jun 20267:00 amRNSChange of Adviser
3rd Jun 20267:46 amRNSDirector Declaration
5th May 20261:03 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSTrading Statement
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20261:44 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSHolding(s) in Company
27th Mar 20262:53 pmRNSHolding(s) in Company
27th Mar 20262:43 pmRNSDirector/PDMR Shareholding
17th Feb 20261:15 pmRNSDirector/PDMR Shareholding
16th Feb 20263:02 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTrading Statement
19th Jan 20268:34 amRNSDirector Declaration
9th Jan 202611:02 amRNSDirector/PDMR Shareholding
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSHalf-year Financial Report
23rd Oct 20255:10 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSTrading Statement
15th Oct 20253:06 pmRNSDirector/PDMR Shareholding
7th Oct 20259:01 amRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNSBoard Fellow Appointment
11th Sep 20251:31 pmRNSResult of AGM
11th Sep 20257:00 amRNSTrading Statement
5th Sep 20253:00 pmRNSDirector/PDMR Shareholding
18th Aug 20251:21 pmRNSDirector/PDMR Shareholding
28th Jul 20253:19 pmRNSDirector/PDMR Shareholding
22nd Jul 20258:08 amRNSNotice of AGM
14th Jul 20251:44 pmRNSDirector/PDMR Shareholding - Replacement
14th Jul 20251:17 pmRNSDirector/PDMR Shareholding
10th Jul 20257:00 amRNSFinal Results
27th Jun 20252:50 pmRNSNotice of Results
4th Jun 20257:00 amRNSTotal Voting Rights
19th May 20255:02 pmRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Update & Notice of FY25 Annual Results
16th Apr 20253:02 pmRNSShare purchases under Dividend Re-Investment Plan
11th Apr 20257:00 amRNSDirector/PDMRs share purchases
2nd Apr 20251:25 pmRNSBlock listing Interim Review
27th Mar 20252:15 pmRNSDirector/PDMR Shareholding
24th Mar 202512:12 pmRNSDirector/PDMR Shareholding - Purchase of Shares
13th Feb 20257:00 amRNSTrading update
5th Feb 202511:19 amRNSDirector/PDMR Shareholding
4th Feb 20253:54 pmRNSDirector/PDMR Shareholding
28th Jan 20252:07 pmRNSDirector/PDMR Shareholding
27th Jan 20255:15 pmRNSDirector/PDMR Shareholding
23rd Jan 20255:27 pmRNSHolding(s) in Company
11th Dec 20241:58 pmRNSHolding(s) in Company
11th Dec 20241:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.